Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Neuroprotection by Tocotrienols in Type 1 and Type 2 Diabetes Mellitus [Phase 3]
Phase 3 clinical trial evaluating neuroprotection by tocotrienols in individuals with Type 1 and Type 2 diabetes mellitus; the study status …
-
CLINICAL_TRIALS research · 2017-05-04Clinical Trial Update: Role of Gastrointestinal Microbes on Digestion of Resistant Starch and Tryptophan Availability to Humans [EARLY_Phase 1]
Clinical trial exploring how gastrointestinal microbes influence digestion of resistant starch and the availability of tryptophan in humans …
-
CLINICAL_TRIALS research · 2017-05-04Clinical Trial Update: Modulating Effects of Oil Palm Phenolics in Uncontrolled Insulin-treated Type 2 Diabetes Mellitus [NA]
A terminated clinical trial from Universiti Sains Malaysia evaluating the effects of oil palm phenolics in uncontrolled insulin-treated type…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Lidocaine + Clonidine for Intraoral Anesthesia in Patients With Diabetes Mellitus Type 2 [Phase 3]
Phase 3 trial evaluating lidocaine with clonidine for intraoral anesthesia in patients with Type 2 diabetes mellitus; results have been post…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Effect of Metformin and Cholecystokinin-mediated Gallbladder Emptying on GLP-1 Secretion in Type 2 Diabetes [NA]
A completed trial evaluating the effect of metformin on GLP-1 secretion via cholecystokinin-mediated gallbladder emptying in type 2 diabetes…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Effect of Bile Acid Secretion and Sequestration on GLP-1 Secretion [NA]
A completed clinical trial investigated how bile acid secretion and sequestration impact GLP-1 secretion in individuals with type 2 diabetes…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Efficacy of a Chronic Care Model Supported by Self Monitoring of Blood Glucose With BGStar Over Usual Care in Improving Glycemic Control in Patients With Type 2 Diabetes Not Treated With Insulin [NA]
A completed clinical trial evaluated whether a chronic care model supported by self-monitoring of blood glucose with BGStar improves glycemi…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Postprandial VLDL-TG Metabolism
A completed clinical trial at the University of Aarhus examining postprandial very-low-density lipoprotein triglyceride metabolism in indivi…
-
CLINICAL_TRIALS research · 2017-05-03Clinical Trial Update: Coaching of Diabetic Patients After Hospital Discharge [NA]
This document is an update on a clinical trial evaluating coaching for Type 2 diabetes patients after hospital discharge; it does not provid…
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Family Consumer Behaviors, Adolescent Prediabetes and Diabetes
A Rutgers University‑sponsored clinical trial focusing on family consumer behaviors related to adolescent prediabetes and diabetes has been …
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Milk Plus Exercise: A Novel Strategy to Treat Diabetes. [NA]
A completed clinical trial investigates 'Milk Plus Exercise' as a strategy to treat Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Effects of Fimasartan on Insulin Secretion in Type 2 Diabetic Patients [NA]
Completed clinical trial evaluating the effects of fimasartan on insulin secretion in patients with type 2 diabetes mellitus and hypertensio…
-
CLINICAL_TRIALS research · 2017-04-28Clinical Trial Update: Integration of Guidelines for Comorbidities [NA]
This clinical trial update from Rambam Health Care Campus outlines a study focused on integrating guidelines for common comorbidities—type 2…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Journey for Control of Diabetes Study (0431-111) [NA]
Clinical trial update for Journey for Control of Diabetes Study (0431-111) indicates the study has completed. It concerns Type 2 Diabetes Me…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: A Randomized Trial of an Intensive Education Intervention Using a Network of Involved Diabetic Patients (Peer Educators) to Improve Glycemic Control of Type 2 Diabetic Patients [NA]
A completed randomized trial assessed an intensive education program delivered by peer educators aimed at improving glycemic control in adul…
-
CLINICAL_TRIALS research · 2017-04-27Clinical Trial Update: The Effect of Empagliflozin on Glucose Metabolism, Weight, Blood Pressure and Cardiac Function (NT-proBNP) Should be Investigated
This clinical trial update discusses investigating empagliflozin's effects on glucose metabolism, weight, blood pressure, and NT-proBNP-rela…
-
CLINICAL_TRIALS research · 2017-04-27Clinical Trial Update: GAPP 1 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Diabetes Mellitus
This document summarizes the completion of the GAPP 1 survey assessing global attitudes of patients and physicians toward insulin therapy in…
-
CLINICAL_TRIALS trial_result · 2017-04-27Clinical Trial Update: Association Between TMAO and Diabetes
The completed clinical trial NCT03130894 studied the association between TMAO and Type 2 diabetes mellitus.
-
CLINICAL_TRIALS withdrawal · 2017-04-26Clinical Trial Update: Enhanced Multicenter Dietary Portfolio Study [NA]
The Enhanced Multicenter Dietary Portfolio Study has been withdrawn. It involved conditions including cardiovascular diseases, Type 2 diabet…
-
FDA approval · 2017-04-25FDA Approved: LIRAGLUTIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for liraglutide submitted by Teva Pharmaceuticals USA, Inc. The approval updates the product’s label…
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: A Clinical Study to Assess the Safety, Tolerability, and Activity of Oral SRT2104 Capsules Administered for 28 Days to Subjects With Type 2 Diabetes Mellitus [Phase 2]
A Phase 2 trial evaluated the safety, tolerability, and activity of oral SRT2104 in Type 2 diabetes mellitus. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Improving Self Management Skills of Older Adults With Diabetes [NA]
This clinical trial update reports on a completed study evaluating an intervention to improve self-management skills in older adults with Ty…
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Induced and Controlled Dietary Ketosis as a Regulator of Obesity and Metabolic Syndrome Pathologies [NA]
This completed clinical trial evaluated whether induced and controlled dietary ketosis can influence obesity-related and metabolic syndrome …
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: The Effect of Pecans on Biomarkers of Risk for Cardiovascular Disease and Diabetes [NA]
A completed Tufts University clinical trial investigated whether pecan consumption influences biomarkers of risk for cardiovascular disease …
-
CLINICAL_TRIALS trial_result · 2017-04-24Clinical Trial Update: The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes [Phase 4]
Phase 4 clinical trial update examining the effect of Byetta (exenatide) and Symlin (pramlintide) on post-meal blood glucose in children wit…